LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)

B. Kasper, R. Ratan, T. Alcindor, P. Schoeffski, Winette T.A. van der Graaf, B.A. Wilky, R.F. Riedel, Annalisa W Lim, L.M. Smith, Sebastian Moody, S. Attia, S.P. Chawla, G. D'Amato, N. Federman, P. Van Tine, B.A. Van Tine, B. Vincenzi, S. Kummar, M.M. Gounder